| answer text |
<p>Understanding the biological mechanisms of COVID-19 and its longer-term impacts
is a priority topic in UK Research and Innovation’s (UKRI) research response. In partnership
with National Institute for Health Research (NIHR), UKRI has announced an £8.4 million
project that will investigate the physical and mental health impacts of hospitalised
patients. The Post-HOSPitalisation COVID-19 (PHOSP-COVID) study, led by Professor
Chris Brightling from the University of Leicester, aims to recruit 8,000 patients
from across the UK. This will make it one of the world’s largest studies into the
long-term health consequences of COVID-19. Results from the study will inform the
development of new and better measures to treat and rehabilitate patients hospitalised
with COVID-19.</p><p>Additional supported work includes a £0.6 million award to Dr
James Peters at Imperial College London for the mechanisms underlying the excessive
inflammatory response developed in a subset of COVID-19 patients, and a £0.8 million
award to Professor John Greenwood Leeds Teaching Hospitals NHS Trust, who will use
magnetic resonance imaging to diagnose and understand cardiac injuries in COVID-19
patients. These awards were made through the UKRI-NIHR COVID-19 Rapid Response Rolling
Call.</p><p> </p>
|
|
